tiprankstipranks
OKYO Pharma Limited Sponsored ADR (OKYO)
NASDAQ:OKYO
US Market
OKYO
OKYO Pharma Limited Sponsored ADR
RESEARCH TOOLSreports
Want to see OKYO full AI Analyst Report?

OKYO Pharma Limited Sponsored ADR (OKYO) Stock News & Sentiment

120 Followers
OKYO Pharma Adds European Eye Disease Expert to Advisory Board as Urcosimod Advances in Neuropathic Corneal Pain
Premium
Company Announcements
OKYO Pharma Adds European Eye Disease Expert to Advisory Board as Urcosimod Advances in Neuropathic Corneal Pain
11d ago
6K
OKYO
OKYO Pharma to Showcase Urcosimod NCP Data at May Ophthalmology Meetings in Denver
Premium
Company Announcements
OKYO Pharma to Showcase Urcosimod NCP Data at May Ophthalmology Meetings in Denver
1M ago
6K
OKYO
OKYO Pharma to Showcase Urcosimod Data and Convene Key Advisory Board at 2026 ASCRS Meeting
Premium
Company Announcements
OKYO Pharma to Showcase Urcosimod Data and Convene Key Advisory Board at 2026 ASCRS Meeting
2M ago
6K
OKYO
OKYO Pharma Chairman Increases Stake Following Positive Neuropathic Corneal Pain Trial
Premium
Company Announcements
OKYO Pharma Chairman Increases Stake Following Positive Neuropathic Corneal Pain Trial
2M ago
6K
OKYO
OKYO Pharma Director Boosts Stake as Lead Eye-Pain Drug Advances Toward Phase 2b/3
Premium
Company Announcements
OKYO Pharma Director Boosts Stake as Lead Eye-Pain Drug Advances Toward Phase 2b/3
2M ago
6K
OKYO
OKYO Pharma Executive Increases Stake Following Positive Urcosimod Trial Progress
Premium
Company Announcements
OKYO Pharma Executive Increases Stake Following Positive Urcosimod Trial Progress
2M ago
6K
OKYO
OKYO Pharma Raises About $22 Million After Underwriter Partially Exercises Share Option
Premium
Company Announcements
OKYO Pharma Raises About $22 Million After Underwriter Partially Exercises Share Option
3M ago
6K
OKYO
More OKYO News >

OKYO News on the Web

OKYO Pharma expands scientific advisory board with cornea expert - ICYMI
Proactive Investors
Bullish
OKYO Pharma adds ophthalmology specialist Marta Sacchetti to Scientific Advisory Board
Proactive Investors
Bullish
OKYO Pharma Adds European Eye Disease Expert to Advisory Board as Urcosimod Advances in Neuropathic Corneal Pain
TipRanks News
Neutral
OKYO Pharma to Showcase Urcosimod NCP Data at May Ophthalmology Meetings in Denver
TipRanks News
Neutral
Piper Sandler Reaffirms Their Buy Rating on OKYO Pharma Limited Sponsored ADR (OKYO)
TipRanks News
Bullish
OKYO Pharma to hold Scientific Advisory Board meeting at ASCRS 2026
Proactive Investors
Bullish
OKYO Pharma advances clinical strategy with SAB meeting and ASCRS presentation
Proactive Investors
Bullish
OKYO Pharma to Showcase Urcosimod Data and Convene Key Advisory Board at 2026 ASCRS Meeting
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average1 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OKYO’s Media Buzz Sentiment?
Currently, no data Available
What is OKYO’s weekly average amount of articles?
In an average week, 1 articles about OKYO are published.
    What is OKYO’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    AKTXAkari Therapeutics
    IMMXImmix Biopharma
    SYSo-Young International
    ADOAnteoTech Ltd
    FSPKFFisher & Paykel Healthcare Corporation Limited
    Showing the stocks with the most bullish news sentiment over the past week